$111.02
3.55% yesterday
NYSE, Feb 28, 04:46 pm CET
ISIN
US7140461093
Symbol
RVTY

PerkinElmer Stock price

$115.11
-8.95 7.21% 1M
-6.07 5.01% 6M
+3.50 3.14% YTD
+11.15 10.73% 1Y
-64.50 35.91% 3Y
+29.11 33.85% 5Y
+68.11 144.91% 10Y
NYSE, Closing price Wed, Feb 26 2025
-0.38 0.33%
ISIN
US7140461093
Symbol
RVTY
Sector

Key metrics

Market capitalization $13.27b
Enterprise Value $15.44b
P/E (TTM) P/E ratio 45.85
EV/FCF (TTM) EV/FCF 28.50
EV/Sales (TTM) EV/Sales 5.60
P/S ratio (TTM) P/S ratio 4.82
P/B ratio (TTM) P/B ratio 1.74
Dividend yield 0.25%
Last dividend (FY24) $0.28
Revenue growth (TTM) Revenue growth 0.16%
Revenue (TTM) Revenue $2.76b
EBIT (operating result TTM) EBIT $410.52m
Free Cash Flow (TTM) Free Cash Flow $541.65m
Cash position $1.16b
EPS (TTM) EPS $2.41
P/E forward 45.34
P/S forward 4.69
EV/Sales forward 5.45
Short interest 4.32%
Show more

Is PerkinElmer a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

PerkinElmer Stock Analysis

Unlock Scores for Free

Analyst Opinions

21 Analysts have issued a PerkinElmer forecast:

13x Buy
62%
7x Hold
33%
1x Sell
5%

Analyst Opinions

21 Analysts have issued a PerkinElmer forecast:

Buy
62%
Hold
33%
Sell
5%

Financial data from PerkinElmer

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
2,755 2,755
0% 0%
100%
- Direct Costs 1,270 1,270
2% 2%
46%
1,485 1,485
2% 2%
54%
- Selling and Administrative Expenses 450 450
12% 12%
16%
- Research and Development Expense 197 197
9% 9%
7%
838 838
1% 1%
30%
- Depreciation and Amortization 428 428
1% 1%
16%
EBIT (Operating Income) EBIT 411 411
3% 3%
15%
Net Profit 296 296
59% 59%
11%

In millions USD.

Don't miss a Thing! We will send you all news about PerkinElmer directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment comprises of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937 and is headquartered in Waltham, MA.

Head office United States
CEO Prahlad Singh
Employees 11,000
Founded 1937
Website www.revvity.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today